Technology
Applications
Resources
Support
Company
Contact
EN
EN
- Global
CN
- 中国
menu
Close
Home
Technology
Applications
Pharmacogenetics
Liquid Biopsy
Mutation Profiling
Hereditary Genetics
Methylation
Sample Integrity
Specimen Validity
Services
Assays by Agena
Certified Service Providers
Resources
Product Literature
Publication Library
Support
Service Plans
Distributors
Certified Service Providers
Company
Careers
Press
Contact
Customer Support Portal
Home
Technology
Applications
Pharmacogenetics
Mutation Profiling
Liquid Biopsy
Hereditary Genetics
Methylation
Sample Integrity
Specimen Validity
Services
Assays by Agena
Certified Service Providers
Resources
Product Literature
Publication Library
Support
Service Plans
Distributors
Certified Service Providers
Company
Careers
Press
Contact
Customer Support Portal
Phone: (858) 882-2800
Home
/
Resources
/
Publication Library
Search Results for: Mutation Profiling
Search All publications
How recent?
Search
Secondary biopsy of non-oncogenic-driven lung cancer may reveal a clinically sensible histologic change. A brief report of two paradigmatic cases
New somatic BRAF splicing mutation in Langerhans cell histiocytosis
Novel combinations of PI3K-mTOR inhibitors with dacomitinib or chemotherapy in PTEN-deficient patient-derived tumor xenografts
Oncogene mutation profile predicts tumor regression and survival in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and radical surgery
Mass spectrometry-based assay for the molecular diagnosis of glioma: concomitant detection of chromosome 1p/19q codeletion, and IDH1, IDH2, and TERT mutation status
MET exon 14 mutations as targets in routine molecular analysis of primary sarcomatoid carcinoma of the lung
Metastatic thyroid carcinoma without identifiable primary tumor within the thyroid gland: a retrospective study of a rare phenomenon
Molecular and Clinicopathological Differences by Age at the Diagnosis of Colorectal Cancer
HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium
Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies
«
...
10
20
...
31
32
33
34
35
...
40
50
...
»